Differential regional cerebral uptake of 18F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis

被引:35
作者
Santens, P
De Bleecker, J
Goethals, P
Strijckmans, K
Lemahieu, I
Slegers, G
Dierckx, R
De Reuck, J
机构
[1] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Div Nucl Med, B-9000 Ghent, Belgium
[3] Univ Ghent, PET Ctr UZ RUG, B-9000 Ghent, Belgium
[4] Univ Ghent, Analyt Chem Lab, B-9000 Ghent, Belgium
[5] Univ Ghent, Dept Elect & Informat Syst, B-9000 Ghent, Belgium
[6] Univ Ghent, Dept Radiopharm, B-9000 Ghent, Belgium
关键词
positron emission tomography; Alzheimer's disease; frontotemporal dementia; diagnosis; metabolism;
D O I
10.1159/000052084
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this paper, the cerebral uptake of F-18-fluoro-2-deoxy-D-glucose (FDG) was studied in a relatively small group of patients suffering from either clinically diagnosed Alzheimer's disease (AD) or frontotemporal dementia during the initial differential diagnostic workup, The image analysis was done visually and semiquantitatively using three different reference regions. Visual analysis confirmed earlier literature findings on the distribution of decreased FDG uptake and demonstrated prevalent asymmetric patterns in both groups. Only semiquantitative analysis using the sensorimotor cortex as a reference region confirmed the visual findings, Moreover, there were no differences in medial temporal robe activities between both groups, and there was no correlation of medial temporal lobe activity with dementia severity. In the AD group, a correlation of parietal FDG uptake with MMSE scores was found. Copyright 2001 S. Karger AG, Basel.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 48 条
[1]   CROSSED CEREBELLAR AND UNCROSSED BASAL GANGLIA AND THALAMIC DIASCHISIS IN ALZHEIMERS-DISEASE [J].
AKIYAMA, H ;
HARROP, R ;
MCGEER, PL ;
PEPPARD, R ;
MCGEER, EG .
NEUROLOGY, 1989, 39 (04) :541-548
[2]   Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease [J].
Albin, RL ;
Minoshima, S ;
DAmato, CJ ;
Frey, KA ;
Kuhl, DA ;
Sima, AAF .
NEUROLOGY, 1996, 47 (02) :462-466
[3]   RELIABILITY AND VALIDITY OF NINCDS-ADRDA CRITERIA FOR ALZHEIMERS-DISEASE - THE NATIONAL-INSTITUTE-OF-MENTAL-HEALTH GENETIC INITIATIVE [J].
BLACKER, D ;
ALBERT, MS ;
BASSETT, SS ;
GO, RCP ;
HARRELL, LE ;
FOLSTEIN, MF .
ARCHIVES OF NEUROLOGY, 1994, 51 (12) :1198-1204
[4]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[5]  
BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416
[6]   Alzheimer disease: Improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections [J].
Burdette, JH ;
Minoshima, S ;
Borght, TV ;
Tran, DD ;
Kuhl, DE .
RADIOLOGY, 1996, 198 (03) :837-843
[7]   ASSESSMENT OF CEREBRAL PERFUSION WITH SINGLE-PHOTON EMISSION TOMOGRAPHY IN NORMAL SUBJECTS AND IN PATIENTS WITH ALZHEIMERS-DISEASE - EFFECTS OF REGION OF INTEREST SELECTION [J].
CLAUS, JJ ;
VANHARSKAMP, F ;
BRETELER, MMB ;
KRENNING, EP ;
VANDERCAMMEN, TJM ;
HOFMAN, A ;
HASAN, D .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (10) :1044-1051
[8]  
CUMMINGS J, 1996, CLIN DIAGNOSIS MANAG, P3
[9]   POSITRON EMISSION TOMOGRAPHY IN ALZHEIMERS-DISEASE [J].
DUARA, R ;
GRADY, C ;
HAXBY, J ;
SUNDARAM, M ;
CUTLER, NR ;
HESTON, L ;
MOORE, A ;
SCHLAGETER, N ;
LARSON, S ;
RAPOPORT, SI .
NEUROLOGY, 1986, 36 (07) :879-887
[10]   SENSITIVITY AND SPECIFICITY OF POSITRON EMISSION TOMOGRAPHY AND MAGNETIC-RESONANCE-IMAGING STUDIES IN ALZHEIMERS-DISEASE AND MULTI-INFARCT DEMENTIA [J].
DUARA, R ;
BARKER, W ;
LOEWENSTEIN, D ;
PASCAL, S ;
BOWEN, B .
EUROPEAN NEUROLOGY, 1989, 29 :9-15